FDA warns of eosinophilic pneumonia risk with Cubicin - ONA
Links shared publicly online about this topic.
- 987total visits
FDA warns of eosinophilic pneumonia risk with Cubicin - ONA
View full resource at oncologynurseadvisor.com
Tags: Pneumonia, Healthcare, FDA, Antibiotic
Most Recently Shared on July 29, 2010 at 4:11 pm By:
FDA warns of eosinophilic pneumonia risk with Cubicin http://goo.gl/fb/EeN7V
Eosinophilic Pneumonia Linked With Cubicin Use
medicalnewstoday.com — “FDA releases drug safety communication warning of potential to acquire this serious condition when receiving intravenous antibacterial daptomycin.Patients and health professionals have” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2010 at 12:05 pm By:
Eosinophilic Pneumonia Linked With Cubicin Use http://mnt.to/3GSp #viruses #bacteria
The FDA warns about pneumonia caused by antibiotic Cubicin - latimes.com
latimes.com — “The Food and Drug Administration Thursday warned physicians and patients that the intravenous antibiotic Cubicin can cause life-threatening eosinophilic pneumonia, which is marked by the accumulation of a type of white blood cells called eosinophils in the lungs. Symptoms include fever, cough, shortness of breath and difficulty breathing.” View full resource at latimes.com
Most Recently Shared on July 31, 2010 at 6:20 pm By:
#FDA warns about #pneumonia caused by #antibiotic #Cubicin http://ow.ly/2iFso
FDA warns about pneumonia risk linked to antibiotic Cubicin - Related Stories - ANA SmartBrief
smartbrief.com — “The FDA said patients treated with Cubist Pharmaceuticals' injectable antibiotic Cubicin might deve” View full resource at smartbrief.com
Most Recently Shared on July 30, 2010 at 5:22 pm By:
FDA warns about pneumonia risk linked to antibiotic Cubicin http://sbne.ws/r/5ggy #fb
Cubicin Side Effects May Increase Pneumonia Risk: FDA - AboutLawsuits.com
aboutlawsuits.com — “Federal drug safety regulators are warning doctors and patients that the intravenous antibiotic Cubicin may increase the risk of pneumonia. On Thursday,” View full resource at aboutlawsuits.com
Most Recently Shared on July 30, 2010 at 2:32 pm By:
Cubicin Side Effects May Increase Pneumonia Risk: FDA - AboutLawsuits.com: http://bit.ly/dhpN2y via @addthis
FDA MedWatch - Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia - Drugs.com MedNews
drugs.com — “ROCKVILLE, Md., July 29, 2010-ISSUE FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatmen” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 11:39 am By:
FDA MedWatch - Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia: ROCKVILLE, Md., J... http://bit.ly/b9uuaB
FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
drugs.com — “FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 2:34 am By:
FDA Alert - FDA Warns of Eosinophilic Pneumonia Risk with Cubicin (daptomycin) - http://bit.ly/d3yDrx
Medical News: FDA Finds Pneumonia Risk with Daptomycin - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The FDA said that the intravenous antibiotic daptomycin (Cubicin) may be linked to an increased risk of eosinophilic pneumonia -- a rare but serious potential side effect -- and requested that a new d” View full resource at medpagetoday.com
Most Recently Shared on July 29, 2010 at 5:41 pm By:
FDA Finds Pneumonia Risk with Daptomycin (MedPage Today) -- The FDA said that the intravenous antibiotic daptomycin (Cu.. http://dld.bz/ppsG
FDA warns of eosinophilic pneumonia risk with Cubicin - MPR
empr.com — “The FDA has notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia while receiving the antibiotic Cubicin (daptomycin, from Cubist).” View full resource at empr.com
Most Recently Shared on July 29, 2010 at 4:02 pm By:
MPR News: FDA warns of eosinophilic pneumonia risk with Cubicin: The FDA has notified healthcare professionals and... http://bit.ly/9UDpdZ
Advertisement

